ABBV
53
2
CAG
36
-3
MAS
70
3
NFLX
58
3
TEL
66
3
ILMN
44
2
PGR
65
-3
M
17
3
PWR
67
7
TXN
53
3
EMR
60
3
CL
56
-2
AVGO
49
9
CMI
56
5
NDAQ
63
4
COP
54
3
MS
57
7
BRK.B
45
3
IRM
68
-3
ADSK
67
2
ABBV
53
2
CAG
36
-3
MAS
70
3
NFLX
58
3
TEL
66
3
ILMN
44
2
PGR
65
-3
M
17
3
PWR
67
7
TXN
53
3
EMR
60
3
CL
56
-2
AVGO
49
9
CMI
56
5
NDAQ
63
4
COP
54
3
MS
57
7
BRK.B
45
3
IRM
68
-3
ADSK
67
2
Financhill
Back

Can Fite Biofarma Vs. Mirum Pharmaceuticals Industry Stock Comparison

Sell
42

CANF
Can Fite Biofarma

Last Price:
2.04
Seasonality Move:
6.52%
Sell
44

MIRM
Mirum Pharmaceuticals

Last Price:
39.35
Seasonality Move:
5.99%
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $2.02. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy, Sell or Hold?

  • The current Mirum Pharmaceuticals [MIRM] share price is $39.34. The Score for MIRM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $2.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.

MIRM Stock Price Chart

What is Mirum Pharmaceuticals's stock price today?

  • The Mirum Pharmaceuticals share price today is $39.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 34.24 Sell
Chaikin Money Flow: -73763 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.19 - 2.43) Sell
Bollinger Bands (100): (2.12 - 3.14) Sell

MIRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 44.04 Sell
Chaikin Money Flow: 27576 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.13 - 42.69) Sell
Bollinger Bands (100): (27.3 - 41.42) Buy

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.27 Sell
20-day SMA: 2.28 Sell
50-day SMA: 2.77 Sell
200-day SMA: 2.37 Sell
8-day EMA: 2.21 Sell
20-day EMA: 2.32 Sell
50-day EMA: 2.52 Sell
200-day EMA: 2.59 Sell

MIRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.48 Sell
20-day SMA: 41.45 Sell
50-day SMA: 40.72 Sell
200-day SMA: 31.06 Buy
8-day EMA: 40.12 Sell
20-day EMA: 40.8 Sell
50-day EMA: 39.41 Sell
200-day EMA: 32.87 Buy

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.

Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Mirum Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):